8:32 pm
939 hits 8 pm May 6 to 8 pm May 7
Cities" when running for council...and they did run...the voters...
2)When they screw you like Uncle Dickie Caraviello tried Tuesday
blurt your REAL subject matter they attempted to steal from you
during your name and address: Your Devoted Editor: Knight Police Report
3)then Dickie and Clerk Hurtubise step in it and you get to file a
couple of Open Meeting Law violations
4)get complaints to Neil Osborne just for fun (his paycheck
keeps Neil from being honest,) State Ethics Commission, AG Complaint
you know the drill.
But HydroClockzohBenzadrineSnakeOil, really, Tricia. Still love ya,
but definitely fear for your mental health on this one.
On April 27, she posted her support of President Donald Trump:
Hydroxychloroquine works if given early. President Trump we are with you. Many of us doctors know it and have used it. Don’t stop speaking up for us. @realDonaldTrump @MarkMeadows @TuckerCarlson @IngrahamAngle @DonaldJTrumpJr @POTUS @VP @GovMikeHuckabee @PastorBroden
— Stella Immanuel MD (@stella_immanuel) April 27, 2020
Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) (HYDRA)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
‘This is insane!’ Many scientists lament Trump’s embrace of risky malaria drugs for coronavirus
When President Donald Trump recently touted the common malaria treatments hydroxychloroquine and chloroquine as potential remedies for coronavirus disease 2019 (COVID-19), he ignited unprecedented demand for the drugs—and set scientists’ teeth on edge. Although the World Health Organization (WHO) agrees the compounds are worth testing more fully on the pandemic coronavirus, few drug or infectious disease experts—not even the president’s own advisers—share his optimism that the drugs could become “one of the biggest game changers in the history of medicine,” as he tweeted. And many are critical of the small French clinical study of just 42 patients that seems to have touched off most of the excitement.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.